Skip to Main Content

Paper Details

Avelumab in paediatric patients with refractory or relapsed solid tumours: dose-escalation results from an open-label, single-arm, phase 1/2 trial.
Cancer Immunol Immunother
9
2022
Author NameAffiliation
David M LoebChildren's Hospital at Montefiore
Ji Won LeeSamsung Medical Center, Sungkyunkwan University School of Medicine
Alexandra P ZorziChildren's Hospital
  • 1 - 3

Datasets

Release 1.2